Showing results (181-190 of 216) with videos related to
Sort By:
Pageof 22
Journal of Hepatology|July 11, 2020
Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitisAmédée Renand, Iñaki Cervera-Marzal, Laurine Gil, et al.Nature Communications|October 28, 2018
IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primatesLyssia Belarif, Caroline Mary, Lola Jacquemont, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 25, 2018
High circulating CD4+CD25hiFOXP3+ T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndromeMaxim Durand, Philippe Lacoste, Richard Danger, et al.The Journal of Clinical Investigation|November 10, 2015
Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survivalGrégoire Couvrat-Desvergnes, Apolline Salama, Ludmilla Le Berre, et al.Journal of Autoimmunity|October 22, 2017
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosisBryan Nicol, Marion Salou, Isabel Vogel, et al.Journal of Autoimmunity|May 5, 2019
BOB.1 controls memory B-cell fate in the germinal center reactionMaartje J Levels, Cynthia M Fehres, Lisa G M van Baarsen, et al.Brain Communications|March 13, 2023
Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammationArnaud B Nicot, Jean Harb, Alexandra Garcia, et al.Kidney International|March 29, 2023
Subclinical rejection-free diagnostic after kidney transplantation using blood gene expressionRichard Danger, Ludmilla Le Berre, Marion Cadoux, et al.Frontiers in Medicine|June 2, 2023
An exome-wide study of renal operational toleranceAnnick Massart, Richard Danger, Catharina Olsen, et al.Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.Pageof 22